These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 8529388)

  • 1. Effect of continuous hemodiafiltration on IL-6, TNF-alpha, C3a, and TCC in patients with SIRS/septic shock using two different membranes.
    Braun N; Rosenfeld S; Giolai M; Banzhaf W; Fretschner R; Warth H; Weinstock C; Deppisch R; Erley CM; Müller GA
    Contrib Nephrol; 1995; 116():89-98. PubMed ID: 8529388
    [No Abstract]   [Full Text] [Related]  

  • 2. Discrimination of sepsis and systemic inflammatory response syndrome by determination of circulating plasma concentrations of procalcitonin, protein complement 3a, and interleukin-6.
    Selberg O; Hecker H; Martin M; Klos A; Bautsch W; Köhl J
    Crit Care Med; 2000 Aug; 28(8):2793-8. PubMed ID: 10966252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytokine-related genotypic differences in peak interleukin-6 blood levels of patients with SIRS and septic complications.
    Watanabe E; Hirasawa H; Oda S; Shiga H; Matsuda K; Nakamura M; Abe R; Nakada T
    J Trauma; 2005 Nov; 59(5):1181-9; discussion 1189-90. PubMed ID: 16385298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High IL-6 serum levels are associated with septic shock and mortality in septic patients with severe leukopenia due to hematological malignancies.
    Antonelli M; Raponi GM; Martino P; Rosa G; Conti G; Jalouk J; Gasparetto A
    Scand J Infect Dis; 1995; 27(4):381-4. PubMed ID: 8658074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating inflammatory mediators predict shock and mortality in febrile patients with microbial infection.
    Groeneveld AB; Tacx AN; Bossink AW; van Mierlo GJ; Hack CE
    Clin Immunol; 2003 Feb; 106(2):106-15. PubMed ID: 12672401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The hemodynamics of human septic shock relate to circulating innate immunity factors.
    Hartemink KJ; Groeneveld AB
    Immunol Invest; 2010; 39(8):849-62. PubMed ID: 20718660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complement activation and the production of inflammatory mediators during the treatment of severe sepsis in humans.
    Dofferhoff AS; de Jong HJ; Bom VJ; van der Meer J; Limburg PC; de Vries-Hospers HG; Marrink J; Mulder PO; Weits J
    Scand J Infect Dis; 1992; 24(2):197-204. PubMed ID: 1641597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pro- and anti-inflammatory responses are regulated simultaneously from the first moments of septic shock.
    Tamayo E; Fernández A; Almansa R; Carrasco E; Heredia M; Lajo C; Goncalves L; Gómez-Herreras JI; de Lejarazu RO; Bermejo-Martin JF
    Eur Cytokine Netw; 2011 Jun; 22(2):82-7. PubMed ID: 21628135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytokine, complement, and endotoxin profiles associated with the development of the adult respiratory distress syndrome after severe injury.
    Donnelly TJ; Meade P; Jagels M; Cryer HG; Law MM; Hugli TE; Shoemaker WC; Abraham E
    Crit Care Med; 1994 May; 22(5):768-76. PubMed ID: 8181284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two types of septic shock classified by the plasma levels of cytokines and endotoxin.
    Endo S; Inada K; Inoue Y; Kuwata Y; Suzuki M; Yamashita H; Hoshi S; Yoshida M
    Circ Shock; 1992 Dec; 38(4):264-74. PubMed ID: 1292890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of severe sepsis and septic shock by CHDF using a PMMA membrane hemofilter as a cytokine modulator.
    Nakamura M; Oda S; Sadahiro T; Hirayama Y; Watanabe E; Tateishi Y; Nakada TA; Hirasawa H
    Contrib Nephrol; 2010; 166():73-82. PubMed ID: 20472994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Western blot analysis of bile or intestinal fluid from patients with septic shock or systemic inflammatory response syndrome, using antibodies to TNF-alpha, IL-1 alpha and IL-1 beta.
    Belov L; Meher-Homji V; Putaswamy V; Miller R
    Immunol Cell Biol; 1999 Feb; 77(1):34-40. PubMed ID: 10101684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patterns of cytokine evolution (tumor necrosis factor-alpha and interleukin-6) after septic shock, hemorrhagic shock, and severe trauma.
    Martin C; Boisson C; Haccoun M; Thomachot L; Mege JL
    Crit Care Med; 1997 Nov; 25(11):1813-9. PubMed ID: 9366763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complement activation and release of interleukin-6 and tumour necrosis factor-alpha in drained and systemic blood after major orthopaedic surgery.
    Krohn CD; Reikerås O; Mollnes TE; Aasen AO
    Eur J Surg; 1998 Feb; 164(2):103-8. PubMed ID: 9537716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TNF-α depuration is a predictor of mortality in critically ill patients under continuous veno-venous hemodiafiltration treatment.
    Quinto BM; Iizuka IJ; Monte JC; Santos BF; Pereira V; Durão MS; Dalboni MA; Cendoroglo M; Santos OF; Batista MC
    Cytokine; 2015 Feb; 71(2):255-60. PubMed ID: 25461406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-1, -6 and tumor necrosis factor-alpha release is down-regulated in whole blood from septic patients.
    Kremer JP; Jarrar D; Steckholzer U; Ertel W
    Acta Haematol; 1996; 95(3-4):268-73. PubMed ID: 8677754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sustained high-efficiency daily diafiltration using a mediator-adsorbing membrane (SHEDD-fA) in the treatment of patients with severe sepsis.
    Nishida O; Nakamura T; Kuriyama N; Hara Y; Yumoto M; Shimomura Y; Moriyama K
    Contrib Nephrol; 2011; 173():172-181. PubMed ID: 21865790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunological status of septic and trauma patients. I. High tumor necrosis factor alpha serum levels in septic and trauma patients are not responsible for increased mortality; a prognostic value of serum interleukin 6.
    Adamik B; Zimecki M; Właszczyk A; Kübler A
    Arch Immunol Ther Exp (Warsz); 1997; 45(2-3):169-75. PubMed ID: 9597083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma concentration of procalcitonin and systemic inflammatory response syndrome after colorectal surgery.
    Sarbinowski R; Arvidsson S; Tylman M; Oresland T; Bengtsson A
    Acta Anaesthesiol Scand; 2005 Feb; 49(2):191-6. PubMed ID: 15715620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complement C3 cleavage and cytokines interleukin-1beta and tumor necrosis factor-alpha in otitis media with effusion.
    Närkiö-Mäkelä M; Teppo AM; Meri S
    Laryngoscope; 2000 Oct; 110(10 Pt 1):1745-9. PubMed ID: 11037838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.